Stocks and Investing Stocks and Investing
Mon, November 15, 2021
Fri, November 12, 2021

Joseph Pantginis Maintained (APTO) at Strong Buy with Increased Target to $210 on, Nov 12th, 2021


Published on 2024-10-27 18:38:43 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Aptose Biosciences Inc." (APTO) at Strong Buy with Increased Target from $135 to $210 on, Nov 12th, 2021.

Joseph, nor any peers, have made any analyst calls on APTO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources